‘Science superpower’ ambitions risk being undermined by lack of investment
Our Director Jeremy Farrar responds to the publication of the Integrated Review.
Search results
Showing 18 results of 18
Gordon Dougan
Director of Infectious Disease (Interim, 2021-2023)
Gordon is an expert in vaccinology, infection and genomics. His research focuses on the genetic and immunological analysis of host/pathogen…
Media statement on Horizon Europe: Urgent resolution needed
Media statement on UK-EU discussions on association to Horizon Europe
Global institutions must act urgently and decisively to tackle Covid-19
The Covid-19 outbreak is not just a public health crisis, it’s rapidly becoming a global crisis – of health, economics and politics.
- Author
Jeremy Farrar
How vaccines and research can help prevent cholera outbreaks
The current cholera pandemic has lasted six decades and killed millions. Professor Jan Holmgren, who developed the world’s first effective oral cholera vaccine, tells us how…
- Author
Jan Holmgren
Five ways to scale up the African vaccine manufacturing industry
How can vaccine manufacturers in Africa expand their manufacturing capacity and capabilities? Deborah King, Vaccines Lead at Wellcome, highlights five key areas for support…
- Author
Deborah King
Low- and middle-income countries
Some of our funding is open to applicants based in low- or middle-income countries. Review a list of countries with low-income or middle-income economies, compiled by the…
The cost of not preparing for infectious diseases
Not preparing for infectious disease outbreaks costs far more than putting the systems in place to prevent them from spreading around the globe. The human and economic…
Horizon Europe: why the UK re-joining is great for science and health
With a new deal struck between the UK and EU on Horizon Europe, we look at why the scheme matters for health research and what needs to happen next.
- Author
Beth Thompson
Could Covid-19 be fuelling drug resistance?
We need to understand the impact of Covid-19 on wider health issues to shape better public health responses and limit long-term consequences. Drug resistance is one of these…
- Author
Gemma Buckland-Merrett
From drug discovery to delivery, we need to do more to fight infectious diseases
The way we tackle infectious diseases is largely led by countries and organisations in the global north, competition and profit. How can we create a better research and…
More than a health crisis: Covid-19 impacts are far-reaching and long-term
Covid-19 is causing wider consequences for societies, national economies and global relations. Three experts share insights on how we can better respond to the pandemic.
Chapter 3: Trust in and perceived value of science amid Covid-19
Wellcome Global Monitor 2020 Chapter 3
Why is a global Covid-19 vaccine rollout vital?
The Covid-19 pandemic is global, and to bring the pandemic to a close, a collaborative, global approach is needed. But why is it so important that all countries have access…
Public Engagement Fund (closed)
This fund enables individuals and organisations to use creative approaches in engaging the public with health research.
Lead applicant career stage:
N/A
Administering organisation location:
N/A
Funding duration:
Up to 3 years
Funding amount:
£25,000 to £3 million
Strategic programme:
Not aligned to our strategic programmes
Frequency:
N/A
Coapplicants:
N/A
Chapter 4: Science and society
This is chapter 4 of the Wellcome Global Monitor 2018.
Chapter 1: Introduction
This is chapter 1 of the Wellcome Global Monitor 2018.
Covid-19: research and projects we've funded
From the development of treatments and vaccines, to support for low- and middle-income countries, we funded a range of Covid-19 research during the…